Bringing the fundamentals into focus…
Back to PROCEPT BioRobotics Corporation
How PROCEPT BioRobotics Corporation stacks up
PRCT · against 424 other Healthcare companies of similar size
Growth
78/ 100
Near the top of its peers.
Ranked #91 of 425 · scores higher than 78% of peers
Bars: peers in each 10-point band of the growth score45 peers with a growth score of 70–79, including PRCT · Click a bar to see the companies
Why growth scores 78?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 81% of peers. Revenue growth: 22.7% vs peer median 6.1%
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 49.2% vs peer median 5.8%
Metric by metric
Position: dot = PRCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 431 reported | 22.7% | 5.4% | 82% | 33% | |
| Earnings per share growthHigher is better · 238 reported | Not reported | 7.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 418 reported | 49.2% | 6.0% | 94% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PRCT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 609M USD | 99 | 91 | |
| 86 | 1.5B USD | 79 | 43 | |
| 86 | 646M USD | 79 | 46 | |
| 91 | 1.8B USD | 78 | 63 | |
| 91 | 549M EUR (≈$604M) | 78 | 56 | |
| 91 | 1.1B USD | 78 | 46 | |
| 94 | 15.3B CNY (≈$2.1B) | 77 | 57 | |
| 94 | 168.6B INR (≈$2.0B) | 77 | 63 | |
| 94 | 1.8B USD | 77 | 31 | |
| 94 | 1.1B USD | 77 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score